Accuray Incorporated (NASDAQ:ARAY) — Market Cap & Net Worth
Market Cap & Net Worth: Accuray Incorporated (ARAY)
Accuray Incorporated (NASDAQ:ARAY) has a market capitalization of $34.30 Million ($34.30 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23365 globally and #5021 in its home market, demonstrating a 2.30% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Accuray Incorporated's stock price $0.34 by its total outstanding shares 118963696 (118.96 Million). Review Accuray Incorporated (ARAY) total liabilities to assess the company's total debt and financial obligations.
Accuray Incorporated Market Cap History: 2015 to 2026
Accuray Incorporated's market capitalization history from 2015 to 2026. Data shows change from $803.00 Million to $40.76 Million (-22.86% CAGR).
Index Memberships
Accuray Incorporated is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #674 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2228 of 3165 |
Weight: Accuray Incorporated's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Accuray Incorporated Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Accuray Incorporated's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Accuray Incorporated's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $547.23 Million | $398.80 Million | -$25.50 Million | 1.37x | N/A |
| 2017 | $511.54 Million | $383.41 Million | -$29.58 Million | 1.33x | N/A |
| 2018 | $405.67 Million | $404.90 Million | -$23.90 Million | 1.00x | N/A |
| 2019 | $335.48 Million | $418.79 Million | -$16.43 Million | 0.80x | N/A |
| 2020 | $496.08 Million | $382.93 Million | $3.83 Million | 1.30x | 129.63x |
| 2021 | $567.46 Million | $396.29 Million | -$6.31 Million | 1.43x | N/A |
| 2022 | $248.63 Million | $429.91 Million | -$5.35 Million | 0.58x | N/A |
| 2023 | $336.67 Million | $447.61 Million | -$9.28 Million | 0.75x | N/A |
| 2024 | $235.55 Million | $446.55 Million | -$15.54 Million | 0.53x | N/A |
| 2025 | $98.10 Million | $458.50 Million | -$1.59 Million | 0.21x | N/A |
Competitor Companies of ARAY by Market Capitalization
Companies near Accuray Incorporated in the global market cap rankings as of June 18, 2026.
Key companies related to Accuray Incorporated by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Accuray Incorporated Historical Marketcap From 2015 to 2026
Between 2015 and today, Accuray Incorporated's market cap moved from $803.00 Million to $ 40.76 Million, with a yearly change of -22.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.76 Million | -58.45% |
| 2025 | $98.10 Million | -58.35% |
| 2024 | $235.55 Million | -30.04% |
| 2023 | $336.67 Million | +35.41% |
| 2022 | $248.63 Million | -56.18% |
| 2021 | $567.46 Million | +14.39% |
| 2020 | $496.08 Million | +47.87% |
| 2019 | $335.48 Million | -17.30% |
| 2018 | $405.67 Million | -20.70% |
| 2017 | $511.54 Million | -6.52% |
| 2016 | $547.23 Million | -31.85% |
| 2015 | $803.00 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Accuray Incorporated was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.30 Million USD |
| MoneyControl | $34.30 Million USD |
| MarketWatch | $34.30 Million USD |
| marketcap.company | $34.30 Million USD |
| Reuters | $34.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more